Skip to content
10-K

Annual Report

Orchestra BioMed Holdings, Inc. OBIO

0001558370-25-004161

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 27, 2025 38.31M sh
Long Term Debt FY 2024 · Dec 31, 2024 $15M
Shares Diluted FY 2024 · Dec 31, 2023 33.23M sh
Capex FY 2024 · Dec 31, 2023 $78K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$46.13M
Cash And Equivalents FY 2024 · Dec 31, 2023 $30.56M
Current Liabilities FY 2024 · Dec 31, 2023 $11.21M
Total Liabilities FY 2024 · Dec 31, 2023 $27.17M
Current Assets FY 2024 · Dec 31, 2023 $89.11M
Total Assets FY 2024 · Dec 31, 2023 $95.21M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.48
Eps Basic FY 2024 · Dec 31, 2023 −$1.48
Sga Expense FY 2024 · Dec 31, 2023 $20.26M
Rd Expense FY 2024 · Dec 31, 2023 $33.82M
Net Income FY 2024 · Dec 31, 2023 −$49.12M
Operating Income FY 2024 · Dec 31, 2023 −$51.51M
Cost Of Revenue FY 2024 · Dec 31, 2023 $186K
Revenue FY 2024 · Dec 31, 2023 $2.76M